Stefan-Erik von Euw
Director/Board Member at NovaHep AB
Stefan-Erik von Euw active positions
| Companies | Position | Start | End |
|---|---|---|---|
NovaHep AB
 NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Director/Board Member | - | - |
Career history of Stefan-Erik von Euw
Former positions of Stefan-Erik von Euw
| Companies | Position | Start | End |
|---|---|---|---|
Alden Impact Capital AG
 Alden Impact Capital AG Investment ManagersFinance Alden Impact Capital AG is a private equity firm with headquarters in Zurich. It was founded in 2011. | Private Equity Investor | 17/02/2011 | 31/12/2017 |
Recopharma AB
 Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden | Director/Board Member | - | - |
Statistics
International
| Sweden | 3 |
| Switzerland | 2 |
Operational
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
Sectoral
| Finance | 2 |
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Alden Impact Capital AG
Alden Impact Capital AG Investment ManagersFinance Alden Impact Capital AG is a private equity firm with headquarters in Zurich. It was founded in 2011. | Finance |
Recopharma AB
Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden | Health Technology |
NovaHep AB
NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Commercial Services |
- Stock Market
- Insiders
- Stefan-Erik von Euw
- Experience
